JO
STOK icon

John Overdeck’s Stoke Therapeutics STOK Stock Holding History

John Overdeck’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
+62,371
New +$2M ﹤0.01% 2982
2025
Q1 		– Sell
-53,950
Closed -$595K – 3475
2024
Q4 		$595K Sell
53,950
-62,728
-54% -$771K ﹤0.01% 2458
2024
Q3 		$1.43M Buy
116,678
+1,773
+2% +$25.1K ﹤0.01% 1889
2024
Q2 		$1.55M Buy
114,905
+99,405
+641% +$1.34M ﹤0.01% 1727
2024
Q1 		$209K Buy
15,500
+4,300
+38% +$26.1K ﹤0.01% 2698
2023
Q4 		$58.9K Sell
11,200
-17,100
-60% -$73.1K ﹤0.01% 2983
2023
Q3 		$112K Buy
28,300
+7,800
+38% +$51.3K ﹤0.01% 2731
2023
Q2 		$218K Buy
20,500
+3,500
+21% +$37.2K ﹤0.01% 2617
2023
Q1 		$142K Sell
17,000
-4,754
-22% -$42.9K ﹤0.01% 2623
2022
Q4 		$201K Sell
21,754
-15,990
-42% -$166K ﹤0.01% 2394
2022
Q3 		$485K Buy
37,744
+21,741
+136% +$346K ﹤0.01% 1795
2022
Q2 		$211K Buy
16,003
+4,761
+42% +$72.3K ﹤0.01% 2144
2022
Q1 		$237K Sell
11,242
-11,285
-50% -$226K ﹤0.01% 2295
2021
Q4 		$540K Sell
22,527
-58,022
-72% -$1.38M ﹤0.01% 3182
2021
Q3 		$2.05M Sell
80,549
-25,365
-24% -$707K ﹤0.01% 1971
2021
Q2 		$3.56M Sell
105,914
-21,452
-17% -$758K 0.01% 1425
2021
Q1 		$4.95M Buy
127,366
+102,426
+411% +$5.83M 0.01% 1051
2020
Q4 		$1.54M Buy
+24,940
New +$1.14M ﹤0.01% 1672

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's STOK Position: Q2 2026 in Review

John Overdeck opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 62,371 shares worth $2.04M. The stake represents ﹤0.01% of the portfolio and ranks #2982 among its holdings. This is a return to the name: John Overdeck previously reported a position in STOK as recently as Q4 2024.

John Overdeck first reported a position in STOK in Q4 2020 and has held it in 18 quarters since. The position peaked at $4.95M in Q1 2021. 196 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • John Overdeck held 62,371 shares of Stoke Therapeutics worth $2.04M as of Q2 2026.
  • Stoke Therapeutics was a new John Overdeck position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2982 holding.
  • John Overdeck first reported a position in Stoke Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • John Overdeck's Stoke Therapeutics position peaked at $4.95M in Q1 2021.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.